#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma recurrent Epidermolysis bullosa Acute lymphocytic leukaemia recurrent Inclusion body myositis Hairy cell leukaemia recurrent Glycogen storage disease type V Penile cancer Thermal burn Granulomatosis with polyangiitis Tuberous sclerosis complex Neuropathic arthropathy Liposarcoma recurrent Pancreatic carcinoma Duchenne muscular dystrophy gene carrier Spina bifida More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma Glycogen storage disease type I – Life with Disease Sjogren’s syndrome – Basic Information X-linked lymphoproliferative syndrome – Diagnostics Antisynthetase syndrome – Treatment Mitochondrial myopathy – Diagnostics Shprintzen-Goldberg syndrome – Trials in Disease Mucopolysaccharidosis Mantle cell lymphoma refractory – Diagnostics Breast angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Maraviroc Saline Setmelanotide SALICYLIC ACID Levobupivacaine Hydrochloride Ep262 Flutafuranol (18F) Midomafetamine Hydrochloride Bevacizumab Deferoxamine Diphenhydramine Vortioxetine Ondansetron LIPASE Larotrectinib Sulfate Tiemonium Methylsulphate Folic Acid, Anhydrous Morf-057 Osteodex Crn04894 More therapies…

    Learn about Your Condition

    Lung disorder Pyrexia Parkinson's disease Immunosuppression Ventricular extrasystoles Migraine H1N1 influenza Prader-Willi syndrome Renal cancer Glioblastoma multiforme Palmoplantar pustulosis Complex regional pain syndrome Cholangiocarcinoma Pterygium Lymphoedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia Denmark Finland France +13

  • Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperoxaluria
    Investigated Drugs:
    • Lumasiran
    Belgium France Italy The Netherlands

  • Study on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Denmark Germany Portugal Sweden

  • Study on Patiromer and Placebo for Managing Hyperkalemia in Non-Dialysis Patients with Chronic Kidney Disease Stages IIIB to V

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperkalaemia
    Investigated Drugs:
    • Calcium Polystyrene Sulfonate
    • Patiromer
    • Iohexol
    Italy

  • Study on the Effect of Patiromer on Vascular Health in Patients with Chronic Kidney Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Patiromer
    Spain

  • Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Ertugliflozin
    • Insulin Glargine
    Austria Czechia Germany Greece Italy Romania +2
Previous Page
1 … 56 57 58 59 60 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!